anti-miR-155-5p antisense oligonucleotide (Celsion Corporation/University of Nevada/NIH/University of South Alabama)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Nameanti-miR-155-5p antisense oligonucleotide (Celsion Corporation/University of Nevada/NIH/University of South Alabama)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNASmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImunon Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity of Nevada National Institutes Of Health University Of South Alabama +[4]

Active IndicationsN/A

Inactive IndicationsAsthma

Other Information

ATC CodeN/A